Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical sevoflurane for pain relief in chronic painful non-healing ulcers
ACTRN12621001093875Phase 4Recruiting
- Sponsor
- Anaesthetic Research Department, Waikato Hospital
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sevoflurane in Peptic ulcer disease (PUD), sponsored by Anaesthetic Research Department, Waikato Hospital. Primary endpoint: Change in maximum pain score during dressing changes. Started Mar 2022; status: recruiting.
02
Drugs
sevoflurane
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on ACTRN12621001093875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001093875.